Sort by
Refine Your Search
-
Listed
-
Field
-
, therapeutic development. His lab employs a multidisciplinary approach, comprising biochemistry and cellular biology as well as global transcriptomic, epigenomic, and 3D chromatin structure analyses, using
-
the supervision of Dr. Merry Mani. The successful candidate will work on the development, validation, and translation of cutting-edge MRI techniques for imaging slow-flowing neurofluids and brain microstructure in
-
of national research infrastructures Evaluating the evolution of Generative AI performance over time and across tasks Analyzing international AI models and their representations of the U.S. in global discourse
-
learning algorithms on graphs to model, characterize, predict, and design the thermal and physical behaviors of diverse material systems. Responsibilities also include the development of software codes
-
applicants interested in developing a research program in the field of cancer biology are welcomed to apply. Expertise in the fields of molecular biology, cell biology, and genetics are expected. Experienced
-
, therapeutic development. His lab employs a multidisciplinary approach, comprising biochemistry and cellular biology as well as global transcriptomic, epigenomic, and 3D chromatin structure analyses, using
-
data issues. Utilizing machine learning techniques as appropriate for data analysis. Developing computing programs and software to support research initiatives. Applying new methodologies to real-world
-
network modeling to address real-world policy challenges through algorithm development and technical analysis. Key Responsibilities Conduct original research in generative AI Train and supervise graduate
-
science of science, network science, and natural language processing. As part of a small research team, the postdoc will help lead efforts to provide a quantitative model of global competitiveness
-
of the brain and development of novel therapeutics. The Mailman lab focuses on mechanisms of drug receptor interaction, and the discovery and development of CNS drugs. Our laboratory discovered the first